Vecuronium falls into the category of non-depolarizing muscle blockers (NMB) and includes others such as pancuronium, rocuronium, atricurium etc. These agents affect only skeletal muscle and do not affect smooth muscle and therefore do not affect GI tract motility. EN can be used safely in these patients and the usual strategies should be used to optimize the benefits and minimize the risks of EN.
Respectfully,
John W. Drover, MD, FRCSC, FACS, CCPE
Professor of Surgery
Chair and Program Medical Director
Critical Care Program
Queen's University
Davies 2
Kingston General Hospital
76 Stuart Street
Kingston, Ontario
Canada
K7L 2V7
Phone 613-549-6666 ext 6335
Fax 613-548-1325
The information contained in this electronic message and any attachments to this message are intended for the exclusive use of the addressee(s) and may contain confidential or privileged information. If the reader of this message is not the intended recipient,
or the agent responsible to deliver it to the intended recipient, you are hereby notified that any review, retransmission, dissemination or other use of this communication is prohibited. If you received this in error, please contact the sender and destroy
all copies of this e-mail.
--
You received this message because you are subscribed to the Google Groups "Critical Care Nutrition" group.
To unsubscribe from this group and stop receiving emails from it, send an email to
criticalcarenutr...@googlegroups.com.
To post to this group, send email to
criticalca...@googlegroups.com.
Visit this group at
http://groups.google.com/group/criticalcarenutrition.
For more options, visit https://groups.google.com/groups/opt_out.
Absolutely not! The oscillator or paralysis either alone or in combination are not a contraindication to EN. Good luck.
John W. Drover, MD, FRCSC, FACS, CCPE
Professor of Surgery
Chair and Program Medical Director
Critical Care Program
Queen's University
Davies 2
Kingston General
Hospital
76 Stuart Street
Kingston, Ontario
Canada
K7L 2V7
Phone 613-549-6666 ext 6335
Fax 613-548-1325
The information contained in this electronic message and any attachments to this message are intended for the exclusive use of the addressee(s) and may contain confidential or privileged information. If the reader of this message is not the intended recipient,
or the agent responsible to deliver it to the intended recipient, you are hereby notified that any review, retransmission, dissemination or other use of this communication is prohibited. If you received this in error, please contact the sender and destroy
all copies of this e-mail.